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Abstract 
Background. Numerous factors influence late-life depressive symptoms in adults, many not 
thoroughly characterized. We addressed whether genetic and environmental influences on 
depressive symptoms differed by age, sex, and physical illness. 
Methods. The analysis sample included 24,436 twins aged 40 through 90 drawn from the Interplay 
of Genes and Environment across Multiple Studies (IGEMS) consortium. Biometric analyses tested 
age, sex, and physical illness moderation of genetic and environmental variance in depressive 
symptoms.  
Results. Women reported greater depressive symptoms than men. After age 60, there was an 
accelerating increase in depressive symptom scores with age, but this did not appreciably affect 
genetic and environmental variances. Overlap in genetic influences between physical illness and 
depressive symptoms was greater in men than in women. Additionally, in men extent of overlap 
was greater with worse physical illness (the genetic correlation ranged from near .00 for the least 
physical illness to nearly .60 with physical illness two SD above the mean). For men and women, 
the same environmental factors that influenced depressive symptoms also influenced physical 
illness.  
Conclusions.  Findings suggested that genetic factors play a larger part in the association between 
depressive symptoms and physical illness for men than for women. For both sexes, across all ages, 
physical illness may similarly trigger social and health limitations that contribute to depressive 
symptoms. 
Key Words: depressive symptoms; twin studies; heritability; aged   
Introduction 
Depressive symptoms are common throughout adulthood. These symptoms often impair 
daily function, especially in older adults, even when their total number does not meet criteria for 
clinical diagnosis (Judd et al., 2002). Both cross-sectional and longitudinal reports have observed 
U-shaped relations between depressive symptom scores and age (Kessler et al., 1992; Sutin et al. 
2013). Additionally, at most ages, women report more depressive symptoms than men, although the 
difference may diminish in very old age (e.g., Berkman et al., 1986; Forlani et al., 2014).  
In older twins, genetic influences generally account for up to 30% of the variance in 
symptom scores (Johnson et al., 2002; Schnittker, 2014). Possible age and sex differences in 
heritability of depressive symptoms have been considered using twin designs. Most find similar 
heritability estimates of depressive symptoms for men and women (Gillespie et al., 2004). Some 
studies have observed greater heritability of depressive symptoms with higher age (e.g., Carmelli et 
al., 2000), although others did not find significant age differences in heritability (McGue & 
Christensen, 1997; Johnson et al., 2002). Because heritability estimates represent the relative 
proportions of genetic and environmental variance components, greater heritability may be a 
function of reduced environmental influences, increased genetic influences, or both.  
Physical illness is a well-established risk factor for depressive symptoms, particularly in 
later life (e.g., Meeks et al., 2000; Djernes, 2006), with these observations not simply due to overlap 
with somatic symptoms used in diagnosing depression (Sutin et al., 2013). Depressive symptoms 
and depressive disorders are elevated among medical inpatients and primary care outpatients 
(Blazer, 2003). The association between depression and physical illness may lie in vascular, 
neuroendocrine, or inflammatory manifestations of physical illness that also contribute to risk for 
explicit depressive symptoms (Fiske et al., 2009; Steptoe, 2007). There may be common factors 
such as low education or high neuroticism that predispose to both physical illness and depression 
(Steptoe, 2007). Physical illness may occasion emotional distress and existential struggles that lead 
to elevated depressive symptoms (Steptoe, 2007). As well, physical illness may impose functional 
limitations and disruptions to daily living that potentiate depression, representing a behavioral 
pathway (Fiske et al., 2009).   
Twin studies can be valuable in illuminating the extents to which genetic and environmental 
sources of influence explain observed covariation between depressive symptoms and physical 
illness. Vulnerability factors in common to physical illness and depressive symptoms, as well as 
proposed physiological pathways linking the two, suggest the possibility that genetic factors 
account for some of the association. Behavioral explanations support roles for environmental 
factors. Physical illness may also moderate genetic and environmental vulnerabilities to depressive 
symptoms, either uniquely or via shared pathways (Johnson, 2007).   
In this paper, we explored the cross-sectional interplay among depressive symptoms, 
physical illness, sex, and age. Prior twin studies of depressive symptoms have not considered the 
role of physical illness, and research pointing to co-occurring physical illness and depressive 
symptoms in older adults has not addressed how genetic and environmental influences interplay. 
We thus examined whether genetic and environmental variance in depressive symptoms varies with 
sex, age, and different levels of physical illness.    
Method 
Participants 
Summarized in Table 1, the sample was drawn from ten independent studies from the 
Interplay of Genes and Environments across Multiple Studies (IGEMS) consortium (Pedersen et al., 
2013). A total of 24,436 individual twins (53.1% women) had relevant data. Depressive symptom 
data were taken from the first occasion at which each participant answered self-report depressive 
symptom questionnaires. Incomplete twin pairs were included, as they are informative about age 
differences in means and variances. Demographic characteristics in Table 1 include numbers of 
monozygotic (MZ), same-sex dizygotic (SSDZ), and opposite-sex dizygotic (OSDZ) pairs. 
Demographics by study are in Table S1.  
Twins in Swedish Adoption Twin Study of Aging (SATSA; Finkel & Pedersen, 2004), 
Origins of Variance in the Oldest-Old (OCTO-Twin; McClearn et al., 1997), Ageing in Women and 
Men: A Longitudinal Study of Gender Differences in Health Behaviour and Health among Elderly 
(GENDER; Gold et al., 2002), and Twin and Offspring Study in Sweden (TOSS; Neiderhiser & 
Lichtenstein, 2008) were ascertained from the population-based Swedish Twin Registry. SATSA 
includes all same-sex twins from the Swedish Twin Registry who were reared apart and a matched 
sample who were reared together, with baseline depressive symptoms assessed at the first 
questionnaire follow-up in 1987. OCTO-Twin includes same-sexed pairs who both survived until 
age 80, with baseline in 1991. GENDER consists of OSDZ twin pairs born 1906 - 1925, with 
baseline in 1994. Baseline for TOSS was 1997 or 2004.  
Longitudinal Study of Aging Danish Twins (LSADT; Christensen et al., 1999) and Middle-
Age Danish Twins (MADT; Skytthe et al., 2013) were ascertained from the Danish Twin Registry. 
LSADT includes same-sex twin pairs age 70 years or older, with baseline in 1995. MADT includes 
both same- and opposite-sex twin pairs born 1931 – 1952, with baseline in 1998.  
The Minnesota Twin Study of Adult Development and Aging (MTSADA; Finkel & McGue, 
1993) includes same-sex twin pairs aged 60 and older ascertained through Minnesota state birth 
records, with baseline data collected 1984 - 1994. The Vietnam Era Twin Study of Aging (VETSA; 
Kremen, et al., 2006) includes male twins aged 51 – 60 at baseline in 2003 – 2007. The twin 
subsample of Midlife in the United States (MIDUS; Kendler et al., 2000) includes same- and 
opposite-sex twin pairs, with depressive symptoms collected at follow-up in 2007.                                                  
The older Finnish Twin Cohort (FTC; Kaprio & Koskenvuo, 2002) is a registry of same-sex 
Finnish twin pairs with age range comparable to the Swedish and Danish twin registries. Depressive 
symptom data reported here come from wave 4 in 2011 (Kaprio, 2013). 
All procedures contributing to this work complied with ethical standards of the relevant 
national and institutional committees on human experimentation and with the Helsinki Declaration 
of 1975, as revised in 2008. 
Previous publications from SATSA (Gatz et al., 1992), LSADT (McGue & Christensen, 
1997), MADT (Johnson et al., 2002), VETSA (Franz et al., 2011), and FTC (Takkinen et al., 2004; 
Korhonen et al., 2007) have presented results from behavior genetic analyses of depressive 
symptoms. The benefits of the IGEMS consortium are a large sample of twins offering increased 
power to detect potentially small moderation effects of physical illness, age, and sex and inclusion 
of a large number of opposite-sex twin pairs to explore potential sex differences in genetic and 
environmental influences on depressive symptoms.  
Zygosity. Specific methods for zygosity determination varied across studies, but in most 
cases involved use of standard questionnaires about physical similarity between twins and DNA 
analysis to resolve uncertain cases.   
Measures  
Depressive symptoms. Two measures of depressive symptoms were used in IGEMS 
studies: the Center for Epidemiologic Studies-Depression (CES-D) scale (Radloff, 1977) and a 
modified version of the Cambridge Mental Disorders of the Elderly Examination (CAMDEX; Roth 
et al., 1986). The CES-D score is the sum of 20 items, each answered from 0-3 to indicate 
frequency of experiencing the symptom during the past week. Four positively worded items were 
reverse-scored so that higher scores indicated more severe depressive symptoms. Previous research 
supports a 4-factor structure representing depressed mood, psychomotor retardation/somatic 
symptoms, lack of well-being (the 4 reverse-scored items), and interpersonal difficulties (Radloff, 
1977; Gatz et al., 1992).  
 The CAMDEX was administered only to Danish twins and consists of 16 items assessing 
frequency of depressive symptoms. Items were answered from 1-3 to indicate frequency of 
experiencing the symptom, except for 2 items rated on a “yes/no” scale. Items were scored so that 
higher scores indicate more severe depressive symptoms. The CAMDEX consists of two factors: 
affective and somatic symptoms (McGue & Christensen, 1997).  
To create a common depressive symptom metric, CESD and CAMDEX scales were 
administered to a separate data-harmonization sample. Item-response theory methods were applied 
to compare items from the two measures and create a conversion table between the scales (Gatz et 
al., 2015b). For substantive comparability, we retained only the 14 CESD items that loaded onto the 
depressed mood and psychomotor retardation/somatic symptoms subscales. The co-calibrated score 
was expressed in CAMDEX units, such that the total score could range from 16 for someone who 
endorsed no symptoms of depression to a maximum of 46 for someone who endorsed the most 
severe frequency of depressive symptoms. Because the harmonized measure did not include the 
same items for those who completed different scales, we calculated separate reliabilities for each 
scale’s harmonization-relevant items. For those who completed the CESD, alpha =.90 (N=16,177), 
while for those who completed the CAMDEX, alpha=.84 (N=8,718).  
Physical illness. To create a harmonized index of physical illness (I-CIRS; Gatz et al., 
2015a), we created a revised version of the Modified Cumulative Illness Rating Scale (CIRS: Salvi 
et al., 2008). I-CIRS is a list of 13 body systems, with a score that represents the number of systems 
with moderate disability or morbidity. All studies had self-reported lists of physical illnesses that 
we recoded to be consistent across IGEMS studies. I-CIRS categories included cardiac; 
hypertension; vascular (circulatory); respiratory; eye, ear, nose and throat; upper gastro-intestinal; 
hepatic; renal; musculoskeletal; neurological (excluding stroke which was rated in a separate 
category); endocrine/metabolic; cancer; and stroke. Each participant received a score from 0-13, 
with higher scores indicating more systems affected by illness. 
Statistical Analysis 
Depressive symptoms and I-CIRS were positively skewed, so scores were log-transformed 
to approximate assumptions of multivariate normality. Depressive symptoms and I-CIRS further 
were standardized (mean= 0, SD=10) to ease computational burden. Twin pairs younger than 40 
(240 complete pairs) or older than 90 (10 complete pairs) were removed from analyses due to 
sparse coverage.  
We examined the phenotypic means of depressive symptoms by sex and linear, quadratic, 
and cubic continuous age using SAS Proc Mixed (SAS Inc., Cary, NC 2013) to account for 
dependencies between members of twin pairs. Intra-pair correlations for depressive symptoms and 
cross-twin cross-trait correlations for depressive symptoms and physical illness were calculated by 
sex, age (by decade), and zygosity (see table S2). To evaluate cohort effects, we formed a sample of 
50- to 59-year-olds tested between 1987 and 1991 (comprised of SATSA and MTSADA) and a 
sample of 50- to 59-year-olds tested between 2003 and 2007 (comprised of TOSS twins from 2004, 
MIDUS twins, and a random sample from VETSA to make the two samples similar in size).   
Twin studies allow variance in a measure to be decomposed into additive genetic variance 
(A), shared environmental variance (C), dominant genetic variance (D), and nonshared 
environmental variance including error (E). Shared environment refers to environmental influences 
that contribute to twin pair similarity, such as rearing environment or contact as adults; nonshared 
environment encompasses influences contributing to differences within a pair. Conventional twin 
methods possess too few degrees of freedom to estimate all ACDE components, but preliminary 
models suggested no evidence of dominant genetic influences. Variance decomposition relies on 
assumptions that SSDZ and OSDZ twins share 50% of their segregating genes, on average, while 
MZ twins share 100% of their genes; and that genetic and environmental biometric components are 
independent. Based on these assumptions, twin (“ACE”) models specify 3 sets of equations based 
on degree of genetic relationship: MZ = covMZ = Va + Vc; SSDZ = covSSDZ = 0.5*Va + Vc; and 
OSDZ = covOSDZ=0.5*Va + Vc.  All multivariate twin models were estimated in OpenMx 2.2.6 
(Neale et al., 2015).  
Qualitative sex differences (i.e., different sources of influences) were tested in univariate 
biometric models by freely estimating the genetic correlation in OSDZ pairs instead of constraining 
it to be .50 as well as freely estimating the shared environmental correlation instead of constraining 
it to be 1.00. An estimated genetic correlation between OSDZ twins significantly less than .50 
suggests qualitative sex differences. Due to documented problems estimating quantitative sex-
limitation in bivariate models (Neale et al., 2006), bivariate moderation models were estimated 
separately for males and females using only SSDZ twins.  To test significance of sex differences we 
constrained parameter estimates for women to equal those for men. We compared this constrained 
model to the model allowing women’s parameter estimates to be freely estimated.   
 We fit age-moderated univariate biometric models (van der Sluis et al., 2012) to address 
whether and how continuous age moderated genetic and environmental variance components 
underlying depressive symptoms. Preliminary results suggested nonlinear age differences in 
depressive symptom scores. These were best characterized as two slopes with a turning point at age 
75 (see Fig. S3). Therefore, we estimated two linear age effects centered at age 75 – with age 
recoded into two variables:  age 40 to 75 (i.e., AgeA=age – 75; if age > 75 then ageA=0) and aged 
75 to 90 (AgeB= age – 75; if age < 75 then ageB=0).  
Under the model, additive genetic, shared environmental, and nonshared environmental 
variances are expressed as:  
𝐴 = 𝑎 + (β𝑎40 ∗ 𝐴𝑔𝑒𝐴) + (β𝑎75 ∗ 𝐴𝑔𝑒𝐵), 
𝐶 = 𝑐 + (β𝑐40 ∗ 𝐴𝑔𝑒𝐴) + (β𝑐75 ∗ 𝐴𝑔𝑒𝐵),  
𝐸 = 𝑒 + (β𝑒40 ∗ 𝐴𝑔𝑒𝐴) + (β𝑒75 ∗ 𝐴𝑔𝑒𝐵). 
The “a” parameter is the estimated additive genetic variance at the age-75 turning point, a40 
is the estimate of the linear slope on additive genetic variance for participants aged 40 - 75, and the 
a75 is the second linear slope for participants aged 75 - 90. The C and E variance components are 
computed in the same way. Likelihood-ratio-tests (LRT) were used to compare nested models.  
We fit continuous age and I-CIRS-moderated bivariate biometric models to test whether I-
CIRS and age moderated genetic and environmental variance between I-CIRS and depressive 
symptoms (Johnson, 2007). Figure 1 depicts the additive genetic variance components of this 
model, which were expressed analogously for the shared and nonshared environmental components 
(not presented). The model estimated the genetic variance of I-CIRS (aCIRS), the genetic covariance 
between I-CIRS and depressive symptoms (acommon), and a genetic variance component unique to 
depressive symptoms (aunique). Age-moderating terms for 40-75 and 75-90 year olds on depressive 
symptoms and I-CIRS were included in the I-CIRS, common, and unique depressive symptoms 
paths. Genetic (rG) and environmental (rC and rE) correlations between I-CIRS and depressive 
symptoms were calculated to aid in interpreting the covariance. The equation for genetic 
correlation, for example, is:  
𝑟𝐺 =  
(𝑎𝑐𝑜𝑚𝑚𝑜𝑛 + (𝛽𝑎40𝑐 ∗ 𝐴𝑔𝑒𝐴) + (𝛽𝑎75𝑐 ∗ 𝐴𝑔𝑒𝐵) + (𝛽𝑎𝐶𝐼𝑅𝑆𝑐 ∗ 𝐶𝐼𝑅𝑆))
√((𝑎𝑐 + (𝛽𝑎40𝑐 ∗ 𝐴𝑔𝑒𝐴) + (𝛽𝑎75𝑐 ∗ 𝐴𝑔𝑒𝐵) + (𝛽𝑎𝐶𝐼𝑅𝑆𝑐 ∗ 𝐶𝐼𝑅𝑆))
2
+
  (𝑎𝑢𝑛𝑖𝑞𝑢𝑒 + (𝛽𝑎40𝑢 ∗ 𝐴𝑔𝑒𝐴) + (𝛽𝑎75𝑢 ∗ 𝐴𝑔𝑒𝐵) + (𝛽𝑎𝐶𝐼𝑅𝑆𝑢 ∗ 𝐶𝐼𝑅𝑆))
2) 
 
 A possible alternative explanation to the variance moderation model is the uniform 
nonlinear main effects model. To address this possible explanation we ran a nonlinear main effects 
model of I-CIRS on depressive symptoms (Van Hulle et al., 2013) and compared this model to the 
variance moderation model. 
Results 
Descriptive Statistics 
 Harmonized depressive symptom scores and I-CIRS scores by age group and sex, pooled 
across studies are shown in Table 1, and by age group in Table S2. Depressive symptom scores 
were positively correlated with physical illness. Results from mixed-effects regression models 
indicated significant age and sex associations with depressive symptoms. Women scored 
significantly higher than men, and both sexes showed accelerating (cubic) score increases with age 
(Fig. S3). The variability of depressive symptoms was greater in women than in men and was larger 
at older ages than at younger ages for both men and women (Table S2). There was no significant 
interaction between age and sex. I-CIRS scores increased quadratically with age in both sexes. The 
phenotypic association between depressive symptoms and physical illness was linear, and 
correlations showed no systematic differences with age.  
There were differences in mean depressive symptom scores across participating studies 
(Table S4). However, differences were not systematic by country or by original measure of 
depressive symptoms, and adding study to the biometric models did not affect findings.  
 Next, we evaluated whether there were cohort differences in depressive symptoms (Table 
S5). We compared 50- to 59-year-olds tested between 1987 and 1991 with 50- to 59-year-olds 
tested between 2003 and 2007 and found no significant differences between the earlier cohort (M = 
20.09, SD = 4.76, N = 402) and the later cohort (M = 20.05, SD = 4.56, N = 400). There was no 
evidence of interaction between sex and cohort.    
 Twin correlations (shown in Table 1) suggested genetic and nonshared environmental 
influences on both depressive symptoms and I-CIRS in male and female twins. For most ages there 
was little evidence of shared environmental influences; however, there was some evidence for them 
(i.e., DZ correlation greater than half the MZ correlation) on depressive symptoms at ages 80-90 
(Table S2). The small but significant MZ and DZ cross-twin cross-trait correlations were similar for 
men but not for women. Similar correlations indicate overlapping shared environmental influences, 
while larger correlations for MZ than for DZ twins suggest that additive genetic effects likely 
mediate the association between the two traits. 
Biometric Model-Fitting Results 
 Age-moderated univariate biometric models with qualitative sex-limitation suggested no 
qualitative sex differences in genetic influences or shared environmental influences on depressive 
symptoms (rG=.50, 95% CI = .39-.50; rC =1.00, 95% CI = 0.91-1.00). This result was expected 
given the similar correlations for OSDZ and SSDZ pairs. Consistent with greater variance in 
women, magnitudes of genetic and environmental influences could not be constrained equal 
without significant deterioration of model fit (see Table S6, with parameter estimates for the full 
univariate model in Table S7). Therefore, separate age-moderated bivariate biometric models were 
calculated for men and for women. Bivariate model-fitting results are shown in Table 2 (with 
additional details in S8 and S9 for males and females, respectively). For both sexes, shared 
environmental influences were very small, not significantly different from 0.00, and could be 
dropped without significant reduction in model fit (see Table 2, model 2). Table 3 presents the 
unstandardized parameter estimates from the best-fitting model, which was model 5 (parameter 
estimates for the full bivariate model are in Table S10). 
 Genetic and environmental influences on depressive symptoms. Results for sex and age 
moderation of depressive symptoms were similar in the univariate analyses of depressive symptoms 
and for influences unique to depressive symptoms in the bivariate model. In the full univariate 
model (Tables S7), additive genetic influences were greater for women than for men; in the best-
fitting bivariate model (Table 3), this pattern held but with the confidence intervals somewhat 
overlapping.  
Figure 2 a-b presents total (common plus unique) unstandardized A and E variance of 
depressive symptoms as a function of age. Although age moderation of influences unique to 
depression could not be dropped, the effects were quite small. Specifically, for both men and 
women, nonshared environmental variances were smaller with greater age until age 75. After age 
75, for men only, nonshared environmental contributions accounted for larger amounts of variance 
at older than at younger ages. Heritability estimates, which represent relative proportions of genetic 
and environmental variance, were not significantly different for men and women: At age 75, h2 for 
men was 28.6% [95% CI = 21.7% - 33.7%] and for women 34.7% [95% CI = 30.6% - 37.8%]. 
GE interplay in association between depressive symptoms and physical illness. Physical 
illness significantly moderated genetic and environmental contributions to depressive symptoms. 
There was significant overlap in both genetic and nonshared environmental influences between I-
CIRS and depressive symptoms. From the information in Table 3, we calculated the proportion of 
variance in depressive symptoms that was shared with physical illness. For men, at age 75, with a 
mean I-CIRS score, 15% (95% CI = 12% - 18%) of the genetic variance and 2% (95% CI = 1% - 
4%) of the nonshared environmental variance in depressive symptoms was shared with physical 
illness. The analogous figures for women were 6% of the genetic variance (95% CI = 3% - 8%) and 
2% (95% CI = 1% - 3%) of the nonshared environmental variance. These figures reflect both the 
greater phenotypic correlation in men and greater I-CIRS variance moderation.   
Consistent with variance moderation, genetic correlations varied with level of physical 
illness for men but not women (Figures 2c and 2d). That is, for men there was greater overlap in 
additive genetic influences underlying I-CIRS and depressive symptoms at higher I-CIRS scores 
than at lower I-CIRS scores, regardless of age. The genetic correlation ranged from near .00 for the 
least physical illness to nearly .60 with physical illness two SD above the mean. Also referring to 
Figures 2c and 2d, environmental factors contributing to twin differences in I-CIRS scores 
accounted for more of the environmental variation in depressive symptoms at higher I-CIRS scores 
than at lower I-CIRS scores in both sexes. As well, referring to eCIRSu in Table 3, for both men and 
women, greater physical illness was associated with greater nonshared environmental contributions 
unique to depressive symptoms.  
Nonlinear and linear means moderation did not provide better model fit in either sex, 
suggesting that nonlinear uniform main effects of I-CIRS on depressive symptoms were not 
explaining the moderation detected in these models. 
Discussion 
We explored the cross-sectional interplay among depressive symptoms, physical illness, 
sex, and age in a combined sample of 24,436 twins aged 40-90. We highlight five findings. First, 
although additive genetic variance in depressive symptoms was greater in women than men, 
heritability of depressive symptoms was not significantly different for men and women. Finding no 
sex differences in heritability is consistent with past work with depressive symptoms (e.g., Johnson 
et al., 2002; Gillespie et al., 2004) although some research has reported greater heritability of 
depressive disorders in women than men (e.g., Bierut et al., 1999; Kendler et al., 2001; Kendler et 
al., 2006). The sex-limitation model indicated that the same genes influenced depression in women 
and men, although others have reported that different genes influenced depressive illness in men 
and women (Kendler & Gardner, 2014).   
Second, for men but not for women, nonshared environmental variance in depressive 
symptoms (i.e., influences on depressive symptoms unique to one individual in a twin pair) was 
greater at higher ages. Some have suggested that men, in particular, may be increasingly sensitive to 
stressful life events—including health issues—with age (Sonnenberg et al., 2000; Kendler & 
Gardner, 2014; Forliani et al., 2014). This account might explain the patterns of nonshared 
environmental variances after age 75. 
Third, physical illness significantly moderated nonshared environmental influences unique 
to depressive symptoms. Regardless of sex, greater self-reported physical illness was associated 
with greater nonshared environmental influences on the unique variance in depressive symptoms.  
Fourth, overlap in genetic influences between physical illness and depressive symptoms was 
greater for men than for women. In men, as well, the genetic correlation between depressive 
symptoms and physical illness was higher with greater physical illness. These effects did not differ 
with age. Analyses of genetic correlations derived from summary statistics of common disorders 
from genome-wide association studies indicate shared genetic effects of major depressive disorder 
with multiple psychiatric, neurological and cardiovascular traits and risk factors (Anttila et al., 
2016). 
Fifth, nonshared environmental influences mediated the association between physical illness 
and depressive symptoms, suggesting small but potentially directly causal influences (Heath et al., 
1993; Turkheimer & Harden, 2013). These environmental influences did not vary with age; 
however, they were stronger with greater physical illness. With poorer health, environmental 
influences that make people ill (e.g. poor diet, lack of physical exercise) may also contribute to 
experiencing more depressive symptoms. 
We note several limitations. First, the data were cross-sectional so intra-individual changes 
in depressive symptoms over time could not be observed. Cohort differences, however, were not 
statistically significant. Additionally, previous research does not suggest secular diminution of 
CES-D scores in younger cohorts (Radloff, 1977; Berkman et al., 1986; Erlich & Isaakowitz, 2002; 
Twenge, 2015). 
Second, reverse causality remains an alternative possibility in this study, including 
reciprocal processes between depressive symptoms and physical illness (Steptoe, 2007; Scott et al., 
2016). Here, longitudinal data are preferable to cross-sectional data to disentangle direction of 
causation (Heath et al., 1993) and dual change mechanisms (McArdle & Hamagami, 2003). Third, 
twins’ histories of depression were unknown. Onset of depressive symptoms in late life might have 
different etiologies than chronic or recurring depressive symptoms (Fiske et al., 2009). Fourth, 
other potential risk factors for depression such as personality characteristics, smoking, use of 
alcohol, and stressful life events unrelated to illness were not included in the models. Fifth, results 
may have been influenced by differences in measurement or recruiting procedures among the 
IGEMS studies, although we were not able to identify any. Sixth, while the sample was large and 
diverse in many respects, population-based, and not selected for depressive symptoms or physical 
illness, ethnic and racial compositions were fairly homogenous.  
Overall, results showed that co-occurring physical illness and depressive symptoms in older 
adults reflects both genetic and environmental mechanisms. Results suggesting shared genes may 
indicate common pathogenic pathways. Those for nonshared environmental influences suggest that 
physically ill twins may face experiences (e.g., functional limitations, pain, disruptions to daily 
living) that lead to decreased physical and social engagement, elevating depressive symptoms 
compared to their physically healthy co-twins. One implication is that alternations in physically ill 
older adults’ environments, such as better chronic-pain treatment, sleep therapy, assistive devices, 
and better overall disease management may offset these effects. Interventions directed at the 
physical symptoms might be paired with behavioral therapies for depression that emphasize 
learning new skills to adapt to physical limitations and challenges.  
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Table 1. Mean scores on depressive symptoms and physical illness (with standard deviations), and 
phenotypic correlations, intra-pair correlations, and cross-twin cross-trait correlations (with 95% 
confidence intervals) 
 
  
 
 
N 
pairs 
 
 
Depressive 
symptoms 
mean(SD) 
 
 
I-CIRS 
Mean 
(SD) 
 
 
Phenotypic 
Correlation 
(95% CI) 
Depressive 
symptoms 
intra-pair 
correlation 
(95% CI) 
 
I-CIRS 
Intra-pair 
correlatio
n 
(95% CI) 
 
Cross-twin 
cross-trait 
correlation 
(95% CI) 
Men 3605 19.43 
(4.17) 
1.59 
(1.66) 
.20 
(.18-.21) 
.25 
(.22-.28) 
.27 
(.24-.30) 
.09 
(.06-.12) 
 
Women 5331 20.42 
(4.80) 
1.97 
(1.80) 
.17 
(.15-.18) 
.24 
(.21-.26) 
.29 
(.26-.31) 
.08 
(.05-.11) 
 
MZM 1621 19.45 
(4.34) 
1.55 
(1.61) 
.19 
(.15-.22) 
.33 
(.28-.37) 
.35 
(.31-.39) 
.08 
(.03-.13) 
 
MZW 1762 20.30 
(4.77) 
1.91 
(1.80) 
.16 
(.13-.19) 
.36 
(.32-.40) 
.38 
(.34-.42) 
.11 
(.06-.15) 
 
DZM 1984 19.60 
(4.15) 
1.63 
(1.71) 
.19 
(.17-.22) 
.18 
(.14-.22) 
.20 
(.16-.24) 
.10 
(.05-.14) 
 
DZW 2416 20.69 
(4.90) 
2.05 
(1.84) 
.15 
(.13-.18) 
.16 
(.12-.20) 
.24 
(.20-.27) 
.04 
(.01-.08) 
 DZOS 1153 19.11 
(3.98) 
1.66 
(1.58) 
.25 
(.22-.29) 
.15 
(.09-.21) 
.24 
(.19-.29) 
.12 
(.06-.17) 
 
Total 8936 19.95 
(4.54) 
1.79 
(1.75) 
.19 
(.18-.20) 
.25 
(.23-.27) 
.29 
(.27-.31) 
.09 
(.07-.11) 
 
Notes: I-CIRS = IGEMS revision of Cumulative Illness Rating Scale; MZM = monozygotic male pairs; 
MZW=monozygotic female pairs; DZM=same-sex dizygotic male pairs; DZW= same-sex dizygotic 
female pairs; DZOS=opposite-sex dizygotic pairs. 
 
 
 
 
 
 
 
  
Table 2. Model fitting results for I-CIRS and age-moderated bivariate biometric models of depressive 
symptoms 
 
 
Notes: More complete model-fitting results in Tables S8 and S9.  -2LL = negative log likelihood 
multiplied by 2; df= degrees of freedom; Comp= model to which compared, Δ-2LL (Δdf) = the 
difference in log likelihood by difference in degrees of freedom between the model being fit and its 
comparison model; A = additive genetic variance; C = shared environmental variance; E = non-shared 
environmental variance; ACE = full model estimating additive genetic, shared environmental, and 
  Men Women 
  
Model 
 
-2LL 
 
df 
 
Comp 
Δ-2LL 
(Δdf) 
 
-2LL 
 
df 
 
Comp 
Δ-2LL 
(Δdf) 
1. Full ACE  108024 14850 - - 126727 17240 - - 
 
2. AE  108032 14861 1 8.14 (11) 126742 17251 1 15.24 (11) 
 
3. Drop all CIRS moderation 108317 14865 2 285.03 
(4)** 
126904 17255 2 161.91 
(4)** 
 
4. Drop age 40-75 covariance 
moderation 
108034 14863 2 2.29 (2) 126744 17253 2 2.23 (2) 
 
5. Drop age 75-90 
covariance moderation 
108036 14865 4 1.19 (2) 12674
4 
17255 4 0.02 (2) 
 
6. Drop age 40-75  
unique depression 
moderation 
108072 14867 5 35.86 (2)** 126759 17257 5 14.11 (2)** 
 
7. Drop age 75-90  
unique depression 
moderation 
108056 14867 5 20.17 (2)** 126754 17257 5 9.02 (2)** 
nonshared environmental variance components; AE= constrained model estimating only additive 
genetic and nonshared environmental variance components; **= significant deterioration in fit 
compared to comparison model. Best-fitting model is shown in bold. 
 
 
 
Table 3. Unstandardized parameter estimates (95% confidence intervals) from the best fitting 
bivariate biometric model from table 2 (model number 5) of depressive symptoms 
 
 Men Women 
  95% CI  95% CI 
Parameter Estimate Lower Upper Estimate Lower Upper 
Additive genetic       
aCIRS 6.00 5.14 6.84 5.18 4.53 5.81 
acommon 0.28 0.22 0.32 0.26 0.18 0.32 
aunique 3.96 3.12 4.74 5.41 4.63 6.16 
aCIRSc 0.16 0.01 0.33 0.01 -0.04 0.07 
a40u -0.06 -0.10 0.01 -0.01 -0.06 0.03 
a75u 0.20 -0.08 0.45 0.16 -0.03 0.34 
aCIRSu 0.03 -0.02 0.08 0.02 -0.02 0.07 
 
Non-shared 
Environmental 
 
eCIRS 7.90 7.35 8.46 7.12 6.69 7.55 
ecommon 0.14 0.10 0.17 0.15 0.12 0.19 
eunique 6.80 6.30 7.32 7.59 7.10 8.10 
eCIRSc 0.09 0.05 0.13 0.11 0.07 0.15 
e40u -0.04 -0.01 -0.07 -0.03 -0.06 -0.01 
e75u 0.16 0.01 0.33 0.03 -0.09 0.16 
eCIRSu 0.10 0.07 0.13 0.06 0.03 0.09 
  
Notes:  aCIRS represents the additive genetic genetic path estimate to the additive genetic I-CIRS factor at 
age 75; acommon = the common pathway estimate of the additive genetic contributions of I-CIRS on 
depressive symptoms; aunique = the estimated variance unique to depressive symptoms at age 75; aCIRSc 
= the estimate of the moderating effect of I-CIRS on the additive genetic covariance. a40u = the estimate 
of the linear slope on the additive genetic variance unique to depressive symptoms for participants 
aged 40 to 75; a75u = the estimate of the linear slope on the additive genetic variance unique to 
depressive symptoms for participants aged 75 to 90. aCIRSu = the estimate of the moderating effect of I-
CIRS on the additive genetic variance unique to depressive symptoms. The parameters denoted with an 
e represent corresponding parameter estimates for the non-shared environmental contributions.   
 
 
 
 
 
Figure 1 
 
 
  
 
Figure 2 
 
 
 
  
Figure captions 
 
 
Figure 1. Diagram of the additive genetic components from the age and I-CIRS moderated bivariate 
biometric model examining physical health (CIRS) and depressive symptoms (DEP). Note that slope 
a40 pertains to individuals age 40-75 while slope a75 pertains to individuals 75 and older. The 
equation for calculating the genetic covariance between I-CIRS and depressive symptoms is the 
product of the pathway shared between CIRS and depressive symptoms and the genetic pathway on 
CIRS. The equation can be written as: (𝑎𝐶𝑜𝑚𝑚𝑜𝑛 +  𝛽𝑎40𝑐 ∗ 𝐴𝑔𝑒𝐴 + 𝛽𝑎𝑠75𝑐 ∗ 𝐴𝑔𝑒𝐵 +   𝛽𝑎𝐶𝐼𝑅𝑆𝑐 ∗
𝐶𝐼𝑅𝑆) ∗ (𝑎𝐶𝐼𝑅𝑆 +  𝛽𝑎40𝐶𝐼𝑅𝑆 ∗ 𝐴𝑔𝑒𝐴 + 𝛽𝑎40𝐶𝐼𝑅𝑆 ∗ 𝐴𝑔𝑒𝐵) 
 
 
 
Figure 2. Graphs of the estimated unstandardized genetic and environmental variance components 
for depressive symptoms for men (panel A) and women (panel B) by age from combining the 
common and unique raw variance estimates from the AE age and I-CIRS moderated bivariate 
biometric model. Graphs of the estimated genetic, and non-shared environmental correlations 
between I-CIRS and depressive symptoms by I-CIRS score for men (panel C) and women (panel D) 
shown at age 75 for purposes of illustration.   
 
Notes: A = additive genetic variance; E = non-shared environmental variance; rG = genetic 
correlation between depressive symptoms and I-CIRS; rE = non-shared environmental correlation 
between depressive symptoms and I-CIRS. Shaded area represents 95% confidence interval of the 
estimate. The I-CIRS score was standardized so the mean CIRS score equals zero and with standard 
deviation equal plus or minus 10. 
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Table S1.Demographic characteristics by study for twin samples with depressive symptoms 
data 
 
Table S2. Mean scores on depressive symptoms and physical illness (with standard deviations), 
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Figure S3. Graphs of estimated depressive symptoms scores by age and sex 
 
Table S4. Means on depressive symptoms by study 
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Table S6. Model comparison results for depressive symptoms from univariate age-moderated 
biometric models 
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age-moderated biometric ACE models of depressive symptoms 
 
Table S8. Bivariate model comparisons for depressive symptoms for males 
 
Table S9. Bivariate model comparisons for depressive symptoms for females.  
 
Table S10. Parameter estimates and 95% confidence intervals for the full bivariate ACE model 
for men and women 
 
  
Table S1. Demographic characteristics by study for twin samples with depressive symptoms 
data 
Study 
N 
Individuals 
% 
Women 
 
Baseline 
year 
# Twin Pairs with 
Complete Data* 
N pairs = 9186 
 
Mean Age 
(SD) 
MZ SSDZ OSDZ 
SATSA 1798 58.5% 1987 218 384 0 61.3 (13.7) 
OCTO-Twin 598 65.9% 1991 114 148 0 83.0 (3.1) 
GENDER 1117 48.8% 1994 0 0 496 74.7 (5.0) 
TOSS 1601 62.9% 1997 or 2004 314 416 0 44.8 (4.9) 
LSADT 4466 58.8% 1995 438 634 16 77.0 (5.4) 
MADT 4303 49.0% 1998 661 599 615 56.4 (6.3) 
MTSADA 1331 58.5% 1984-94 328 277 0 58.1 (10.9) 
VETSA 1229 0.0% 2003-07 345 261 0 55.4 (2.5) 
MIDUS 380 58.4% 2007 81 37 28 57.0 (11.4) 
FTC 8240 55.4% 2011 1009 1767 0 59.8 (3.8) 
Total 25063 53.1% ---- 3509 4522 1156 62.3 (11.3) 
 
  
Table S2. Mean scores on depressive symptoms and physical illness (with standard deviations), 
and phenotypic correlations, intra-pair correlations, and cross-twin cross-trait correlations (with 
95% confidence intervals), by age group 
  Age Group  
  40-49 50-59 60-69 70-79 80-90 Total 
N complete 
pairs 
MZM 161 762 448 178 72 1621 
MZW 263 564 548 265 122 1762 
DZM 213 844 624 231 72 1984 
DZW 294 789 764 377 192 2416 
DZOS 109 303 283 351 107 1153 
Depressive 
symptoms 
mean (SD) 
Men 18.88 
(3.91) 
19.45 
(4.24) 
19.43 
(3.99) 
19.31 
(4.04) 
20.39 
(4.98) 
19.43 
(4.17) 
Women 19.91 
(4.55) 
20.39 
(4.83) 
20.32 
(4.59) 
20.43 
(4.84) 
21.26 
(5.33) 
20.42 
(4.80) 
I-CIRS 
mean (SD) 
Men 0.65 
(0.97) 
1.27 
(1.45) 
1.74 
(1.74) 
2.17 
(1.72) 
2.53 
(1.84) 
1.59 
(1.66) 
Women 0.84 
(1.11) 
1.59 
(1.62) 
2.06 
(1.81) 
2.49 
(1.79) 
2.95 
(1.95) 
1.97 
(1.80) 
Phenotypic 
correlation 
Men .15 
(.08;.21) 
.21 
(.18;.23) 
.19 
(.16;.23) 
.20 
(.16;.24) 
.15 
(.08;.22) 
.20 
(.18;.21) 
Women .08 
(.03;.14) 
.19 
(.16;.22) 
.14 
(.10;.17) 
.19 
(.15;.23) 
.13 
(.08;.18) 
.17 
(.15;.18) 
Depressive 
symptoms- 
intra-pair 
correlation 
MZM .31 
(.16;.44) 
.33 
(.24;.37) 
.34 
(.26;.42) 
.23 
(.08;.36) 
.38 
(.16;.57) 
.33 
(.28;.37) 
 
MZW .33 
(.22;.44) 
.34 
(.26;.41) 
.36 
(.28;.42) 
.39 
(.29;.49) 
.45 
(.30;.58) 
.36 
(.32;.40) 
 
DZM .27 
(.14;.39) 
.23 
(.17;.29) 
.11 
(.03;.18) 
.07 
(-.06;.20) 
.23 
(.01;.44) 
.18 
(.14;.22) 
 
DZW .21 
(.10;.32) 
.17 
(.10;.24) 
.17 
(.10;.24) 
.08 
(-.02;.18) 
.15 
(.01;.29) 
.16 
(.12;.20) 
 
DZOS -.04 
(-.22;.15) 
.14 
(.03;.25) 
.03 
(-.09;.15) 
.15 
(.04;.25) 
.26 
(.08;.43) 
.15 
(.09;.21) 
I-CIRS 
intra-pair 
correlation 
MZM .16 
(.01;.31) 
.31 
(.24;.37) 
.32 
(.24;.40) 
.29 
(.15;.42) 
.35 
(.13;.54) 
.35 
(.31;.39) 
 
MZW .17 
(.05;.28) 
.36 
(.29;.43) 
.31 
(.23;.38) 
.33 
(.21;.43) 
.45 
(.30;.58) 
.38 
(.34;.42) 
 
DZM .02 
(-.12;.15) 
.16 
(.09;.22) 
.19 
(.11;.26) 
.07 
(-.06;.20) 
.04 
(-.19;.27) 
.20 
(.16;.24) 
 
DZW .02 
(-.09;.14) 
.14 
(.07;.20) 
.20 
(.13;.26) 
.13 
(.02;.22) 
.28 
(.15;.41) 
.24 
(.20;.27) 
 
DZOS .32 
(.14;.48) 
.04 
(-.07;.15) 
.06 
(-.05;.18) 
.12 
(.01;.22) 
.05 
(-.19;.27) 
.24 
(.19;.29) 
Cross-twin 
cross-trait 
correlation 
MZM .05 
(-.10;.21) 
.07 
(.01;.14) 
.09 
(.01;.19) 
.09 
(-.06;.23) 
.08 
(-.15;.31) 
.08 
(.03;.13) 
 
MZW .08 
(-.04;.20) 
.13 
(.05;.21) 
.11 
(.02;.19) 
.15 
(.03;.27) 
.07 
(-.11;.25) 
.11 
(.06;.15) 
 
DZM .05 
(-.08;.18) 
.12 
(.05;.18) 
.07 
(-.01;.15) 
.10 
(-.03;.22) 
.05 
(-.18;.28) 
.10 
(.05;.14) 
 
DZW -.05 
(-.17;.06) 
.10 
(.03;.17) 
.05 
(-.02;.12) 
.03 
(-.07;.13) 
.01 
(-.13;.15) 
.04 
(.01;.08) 
 
DZOS .04 
(-.15;.22) 
.02 
(-.09;.14) 
.11 
(-.01;.23) 
.06 
(-.04;.17) 
.14 
(-.01;.36) 
.12 
(.06;.17) 
Figure S3. Graph of estimated depressive symptoms score from the mixed model regression 
with effects for age and sex  
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Table S4. Means (and standard deviations) on depressive symptoms by study 
Study 
Men Women 
Age Group Age Group 
40s 50s 60s 70s 80s 40s 50s 60s 70s 80s 
SATSA 
19.4 
(4.7) 
19.3 
(4.3) 
20.3 
(4.4) 
20.8 
(4.7) 
23.8 
(5.7) 
20.3 
(4.9) 
20.8 
(5.1) 
21.9 
(5.7) 
22.7 
(6.0) 
23.3 
(6.2) 
OCTO-Twin 
    
19.3 
(4.5) 
    19.8 
(4.6) 
GENDER 
  
19.4 
(3.7) 
19.1 
(3.8) 
19.1 
(3.8) 
  20.6 
(4.5) 
20.6 
(4.8) 
19.7 
(3.7) 
TOSS 
19.7 
(3.8) 
20.3 
(4.4) 
   
20.9 
(4.9) 
21.9 
(5.5) 
   
LSADT 
   
19.2 
(4.1) 
21.0 
(5.2) 
   20.1 
(4.6) 
22.0 
(5.6) 
MADT 
17.9 
(3.6) 
17.7 
(2.9) 
18.3 
(3.5) 
  
17.8 
(3.0) 
18.5 
(3.7) 
18.7 
(3.9) 
  
MTSADA 
19.3 
(4.2) 
20.2 
(4.8) 
18.6 
(3.3) 
18.5 
(2.5) 
18.3 
(1.7) 
20.7 
(4.5) 
19.5 
(4.3) 
20.1 
(4.5) 
19.3 
(3.5) 
 
VETSA 
 
19.8 
(4.6) 
   
     
MIDUS 
19.1 
(3.8) 
20.5 
(4.4) 
18.6 
(3.6) 
18.4 
(2.8) 
 
19.5 
(3.7) 
19.2 
(4.4) 
19.0 
(3.6) 
18.6 
(3.4) 
 
FTC 
 
20.2 
(4.3) 
20.1 
(4.1) 
  
 21.2 
(5.0) 
20.9 
(4.6) 
  
 
Note: Cells shown only where N = 15 or greater  
Table S5.  Results of analysis of variance comparing depressive symptoms in two cohorts of 50-
59 year olds. Cohort 1 tested 1987-1991. Cohort 2 tested 2003-2007.  
 
 
N 
(men/women) 
Men 
Mean (SD) 
Women 
Mean (SD) 
Cohort 1 173/229 19.20 (4.13) 20.76 (5.09) 
Cohort 2 295/105 19.90 (4.34) 20.43 (5.15) 
 
 
Source DF Type III SS Mean Square F Value p 
sex 1 188.64 188.64 8.79 <0.01 
cohort 1 5.83 5.83 0.27 0.60 
sex*cohort 1 45.48 45.48 2.12 0.15 
 
 
Table S6. Model comparison results for depressive symptoms from univariate age-moderated models  
 
Model -2LL Df AIC BIC Δ-2LL 
Δdf 
Comp p 
1. Full ACE model-Quantitative sex differences and spline at age 75 174903.20 23677 127551 -52480 - - - 
2. Remove quantitative sex differences  175050.89 23686 127549 -52489 147.69 (9) 1 <0.01 
3. Remove sex differences on A 174913.24 23679 127555 -52498 10.05 (3) 1 0.02 
4. Remove sex differences on E 174924.30 23679 127566 -52487 21.11 (3) 1 <0.01 
5. Drop C-All 174907.73 23683 127542 -52542 4.53 (6) 1 0.61 
6. Remove 75-90- variance age moderation 174962.92 23687 127589 -52526 55.19 (4) 3 <0.01 
7. Remove 40-75- variance age moderation 174917.11 23687 127543 -52571 9.38 (4) 3 0.05 
  
Men 
       
8. Full AE model –age 75 turning point 174907.73 23683 127542 -52542 - - - 
9. Drop all age moderation 174956.58 23687 127583 -52532 48.85 (4) 6 <0.01 
10. Drop A age 75+ slope 174911.81 23684 127544 -52548 4.08 (1) 6 0.04 
11. Drop A age 40-75 slope 174914.69 23684 127547 -52545 6.97 (1) 6 0.01 
12. Drop A both slopes 174916.35 23685 127546 -52553 8.62 (2) 6 0.01 
13. Drop E age 75 slope 174911.42 23684 127543 -52548 3.70 (1) 6 0.05 
14. Drop E age 40-75 slope 174908.73 23684 127541 -52551 1.00 (1) 6 0.32 
15. Drop E both slopes 174914.95 23685 127545 -52554 7.22 (2) 6 0.03 
 
Women 
       
16. Full AE model –age 75 turning point 174907.73 23683 127542 -52542 - - - 
17. Drop all age moderation 174927.86 23687 127554 -52562 20.14 (4) 14 <0.01 
18. Drop A age 75 slope 174910.57 23684 127543 -52549 2.85 (1) 14 0.09 
19. Drop A all age slope 174908.07 23684 127540 -52542 0.34 (1) 14 0.56 
20. Drop A both slopes 174912.41 23685 127542 -52557 4.68 (2) 14 0.10 
21. Drop E age 75 slope 174907.76 23684 127540 -52552 0.03 (1) 14 0.85 
22. Drop E all age slope 174907.79 23684 127540 -52552 0.06 (1) 14 0.81 
23. Drop E both slopes 174907.80 23685 127538 -52561 0.07 (2) 14 0.97 
 
Note: -2LL equals the fit of the model, df= degrees of freedom from the model, AIC = Akaike Information Criterion, BIC = Bayesian 
Information Criterion, LRT = difference in model fit between current model and comparison model, Δdf  = difference in degrees of 
freedom between models, p = probability of the difference between the two models if null hypothesis is true. 
Table S7. Unstandardized parameter estimates (95% confidence intervals) from age-moderated 
univariate biometric (ACE) models of depressive symptoms 
 
 Men Women 
  95% CI  95% CI 
Parameter Estimate Lower Upper Estimate Lower Upper 
Additive 
genetic 
      
a 4.14 2.68 5.14 6.45 5.44 7.20 
a40c -.03 -.10 .03 .05 -.01 .11 
a75c .21 -.11 .42 .12 -.10 .28 
Common 
Environmental 
      
c 1.43 -3.15 3.15 .38 -2.46 2.46 
c40c -.06 -.15 .15 -.10 -.17 .17 
c75c .01 -.01 .04 .03 -.37 .41 
Non-shared 
Environmental 
   
e 7.72 7.24 8.19 8.15 7.66 8.66 
e40 .01 -.01 .04 -.01 -.03 .02 
e75c .01 .12 .26 .12 -.10 .28 
 
 
Notes:  a  represents the additive genetic path estimate for depression at age 75; a40 = the estimate 
of the linear slope on additive genetic variance for participants aged 40 to 75; a75  = the estimate of 
the linear slope on the additive genetic covariance for participants aged 75 to 90; The parameters 
denoted with c and e represent analogous parameter estimates for the shared and non-shared 
environmental contributions. None of the shared parameter estimates was significant. 
 
 
 
 
 
 
 
 
 
 
 
Table S9. Bivariate model comparisons for depressive symptoms for males 
 
Model  
Estimated  
Parameters -2LL df AIC 
 
BIC 
Δ-2LL 
Δdf 
 
Comp p 
Men    
 
    
1. Full ACE Bivariate Moderation Model 39 108024 14850 78324 -14251 - - - 
2. Drop C 28 108032 14861 78310 -14334 8.14 (11) 1 0.70 
3. AE Bivariate drop all CIRS moderation 24 108317 14865 78587 -14082 285.03 (4) 2 <0.01 
4. AE Bivariate drop all CIRS A moderation 26 108043 14863 78316 -14340 9.91 (2) 2 0.01 
5. AE Bivariate drop all CIRS E moderation 26 108083 14863 78357 -14299 51.03 (2) 2 <0.01 
Depression and CIRS common variance         
6. Drop A CIRS common moderation 27 108040 14862 78316 -14335 7.46 (1) 2 0.01 
7. Drop A age 75-90 common moderation 27 108032 14862 78308 -14342 0.01 (1) 2 0.97 
8. Drop A age 40-75 common moderation 27 108034 14862 78310 -14340 2.27 (1) 2 0.13 
9. Drop E CIRS common moderation 27 108045 14862 78321 -14329 12.55 (1) 2 <0.01 
10. Drop E age 75-90 common moderation 27 108033 14862 78309 -14341 0.63 (1) 2 0.43 
11. Drop E age 40-75 common moderation 27 108033 14862 78309 -14341 1.11 (1) 2 0.29 
Unique variance Depression         
12. Drop A CIRS unique moderation 27 108033 14862 78309 -14341 1.01 (1) 2 0.32 
13. Drop A age 75-90 unique moderation 27 108034 14862 78310 -14340 2.10 (1) 2 0.15 
14. Drop A age 40-75 unique moderation 27 108036 14862 78312 -14338 4.24 (1) 2 0.04 
15. Drop E CIRS unique moderation 27 108072 14862 78348 -14302 39.66 (1) 2 <0.01 
16. Drop E age 75-90 unique moderation 27 108036 14862 78312 -14338 4.10 (1) 2 0.04 
17. Drop E age 40-75 unique moderation 27 108039 14862 78315 -14335 6.59 (1) 2 0.01 
 
Note: 2LL equals the fit of the model (2* the negative log likelihood), df= degrees of freedom from the model, AIC = Akaike 
Information Criterion, BIC = Bayesian Information Criterion, Δ-2LL = difference in model fit between current model and comparison 
model, Δdf  = difference in degrees of freedom between models, Comp = comparison model, p = probability of the difference 
between the two models if null hypothesis is true. 
 
Table S9. Bivariate model comparisons for depressive symptoms for females 
Model  
Estimated  
Parameters -2LL df AIC 
 
 
BIC 
Δ-2LL 
Δdf 
 
Comp 
p 
Women     
 
   
1. Full ACE Bivariate Moderation Model 39 126727 17240 92247 
-17827 - - - 
2. Drop C 28 126742 17251 92240 
-17904 15.24 (11) 1 0.17 
3. AE Bivariate drop all CIRS moderation 24 126904 17255 92394 
-17776 161.91 (4) 2 <0.01 
4. AE Bivariate drop all CIRS A moderation 26 1276744 17253 92238 
-17919 1.30 (2) 2 0.52 
5. AE Bivariate drop all CIRS E moderation 26 126777 17253 92271 
-17886 34.50 (2) 2 <0.01 
Depression and CIRS common moderation     
    
6. Drop A CIRS common moderation 27 126743 17252 92239 
-17912 0.29 (1) 2 0.59 
7. Drop A age 75-90 common moderation 27 126742 17252 92238 
-17912 0.01 (1) 2 0.95 
8. Drop A age 40-75 common moderation 27 126742 17252 92238 
-17912 0.09 (1) 2 0.77 
9. Drop E CIRS common moderation 27 126764 17252 92260 
-17890 21.95 (1) 2 <0.01 
10. Drop E age 75-90 common moderation 27 126742 17252 92238 
-17912 0.23 (1) 2 0.63 
11. Drop E age 40-75 common moderation 27 126744 17252 92240 
-17911 1.71 (1) 2 0.19 
Unique variance Depression     
    
12. Drop A CIRS unique moderation 27 126743 17252 92239 
-17911 0.93 (1) 2 0.33 
13. Drop A age 75-90 unique moderation 27 126744 17252 92241 
-17910 2.66 (1) 2 0.10 
14. Drop A age 40-75 unique moderation 27 126743 17252 92239 
-17912 0.30 (1) 2 0.58 
15. Drop E CIRS unique moderation 27 126757 12752 92253 
-17898 14.38 (1) 2 <0.01 
16. Drop E age 75-90 unique moderation 27 126743 12752 92239 
-17912 0.32 (1) 2 0.57 
17. Drop E age 40-75 unique moderation 27 126748 17252 92244 
-17907 5.53 (1) 2 0.02 
 
Note: 2LL equals the fit of the model (2* the negative log likelihood), df= degrees of freedom from the model, AIC = Akaike 
Information Criterion, BIC = Bayesian Information Criterion, Δ-2LL = difference in model fit between current model and comparison 
model, Δdf  = difference in degrees of freedom between models, Comp = comparison model, p = probability of the difference 
between the two models if null hypothesis is true. 
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Table S10. Parameter estimates and 95% Confidence Intervals for the full bivariate ACE model 
for men and women 
 
 Men Women 
  95% CI  95% CI 
Parameter Estimate Lower Upper Estimate Lower Upper 
Additive 
genetic 
      
aCIRS 5.68 -6.68 6.68 5.24 4.09 6.03 
acommon .93 -0.41 2.10 1.12 -.52 2.48 
aunique -4.09 -4.90 4.90 5.37 4.22 6.29 
a40c .01 -.06 .09 .01 -.08 .09 
a75c .03 -.42 .44 -.30 -.67 .12 
aCIRSc .03 -.04 .11 .05 -.02 .12 
a40u .02 -.05 .08 .01 -.06 .08 
a75u -.22 -.49 .37 .12 -.14 .32 
aCIRSu .01 -.06 .08 .05 -.03 .11 
Common 
Environmental 
   
ccirs 1.65 -3.42 3.42 -1.39 -3.10 2.02 
ccommon -.03 -2.04 2.04 -.75 -2.96 2.03 
cunique -.01 -2.55 2.55 -.91 -3.00 3.01 
c40c .13 -.20 .20 .05 -.15 .16 
c75c .27 -.46 .81 -.07 -.39 .22 
cCIRSc -.12 -.18 .18 .03 -.09 .13 
c40u .01 -.14 .14 .01 -.16 .16 
c75u .01 -.73 .73 -.07 -.45 .45 
cCIRSu .01 -13 .13 .10 -.17 .17 
Non-shared 
Environmental 
      
eCIRS 7.96 7.41 8.53 7.13 6.71 7.57 
ecommon 1.46 .78 2.15 1.52 .82 2.22 
eunique 6.76 6.26 7.28 7.54 7.05 8.06 
e40c .02 -.02 .06 .03 -.01 .06 
e75c -.12 -.32 .08 -.04 -.18 .11 
eCIRSc .09 .05 .13 .10 .06 .14 
e40u -.04 -07 -.01 -.03 -.06 -.01 
e75u .13 -.02 .30 .04 -.08 .17 
eCIRSu .10 .07 .13 .05 .02 .08 
 
Notes:  aCIRS represents the additive genetic genetic path estimate to the additive genetic I-CIRS 
factor at age 75; acommon = the common pathway estimate of the additive genetic contributions of I-
CIRS on depressive symptoms; aunique = the estimated variance unique to depressive symptoms at 
age 75; aCIRSc = the estimate of the moderating effect of I-CIRS on the additive genetic covariance. 
a40u = the estimate of the linear slope on the additive genetic variance unique to depressive 
symptoms for participants aged 40 to 75; a75u = the estimate of the linear slope on the additive 
genetic variance unique to depressive symptoms for participants aged 75 to 90. aCIRSu = the 
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estimate of the moderating effect of I-CIRS on the additive genetic variance unique to depressive 
symptoms. The parameters denoted with c represent corresponding parameter estimates for the 
common environmental contributions. The parameters denoted with an e represent corresponding 
parameter estimates for the non-shared environmental contributions.  
 
